Supplementation of Flt3L significantly amplified CD103+CD11c+ DCs and led to higher percentages of tumor-free rates in HCC mice, further underlining the importance of functional host Batf3-dependent DCs in driving DEX-mediated antitumor responses. The gene discussed is ITGAX; the disease is hepatocellular carcinoma.